Using hyaluronic acid to protect, heal, and repair tissue and skin is Anika’s specialty. It also employs the acid in products to combat osteoarthritis.
Company Information
| Location | Bedford, MA |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Fortune 500 Rank | - |
| Fortune 500 Profile | - |
| Current Streak | 1 |
| Years on List | 1 |
| CEO | Charles H. Sherwood |
| Website | http://www.anikatherapeutics.com |
Looking for leads, investment insights, or competitive intelligence?Purchase Now
Revenue, Net Income
| Revenue Past Four Quarters | 87 |
| Net Income Past Four Quarters | 27 |
Growth Rates
| EPS 3 yr Annual Growth Rate | 57% |
| Rev 3 yr Annual Growth Rate | 16% |
| Total Return 3 yr Annual Rate | 34% |
| Beat S&P 3 yr Total Return? | yes |
Rank
| EPS Growth Rank | 41 |
| Revenue Growth Rank | 99 |
| Total Return Rank | 67 |